RYTM

RHYTHM PHARMACEUTICALS INC

Healthcare | Mid Cap

-$0.84

EPS Forecast

$58.16

Revenue Forecast

The company already released most recent quarter's earnings. We will publish our AI's next quarter's forecast around 2026-07-01

Proximilar's AI forecasts

EPS Forecast:

-$0.84

Revenue Forecast:

$58.16

EPS Surprise Forecast:

-$0.001

Revenue Surprise Forecast:

$1

Post-release price volatility - High

Post-release Overnight Move:

±9.0%

Post-release 1-week Move:

±

Odds of beating consensus

Probability of beating EPS consensus:

53%

Probability of beating revenue consensus:

65%

Probability of beating both EPS & revs consensus:

41%

Probability of missing both EPS & revs consensus:

23%

Surprise rating (from -5 to 5)

How unusually large is the +/- surprise we forecast:

-3

Beta (β)

Forward Looking Beta (β):

0.94

Earnings volatility

EPS standard deviation:

$0.26

Revenue standard deviation:

$9

As % of share price:

0.29% MEDIUM

As % of market cap:

0.14% LOW

Confidence intervals and percentiles

EPS 95th %ile:

-$0.49

Revenue 95th %ile:

$70

EPS 75th %ile:

-$0.75

Revenue 75th %ile:

$61

EPS 25th %ile:

-$0.91

Revenue 25th %ile:

$55

EPS 5th %ile:

-$1.12

Revenue 5th %ile:

$48

Correlation of surprises (strength of relationship)

Correlation between EPS & revenue surprises:

44% HIGH

Earnings sensitivity to revenue surprises (slope of regression line)

Expected % of revenue surprise going to EPS:

89% VERY HIGH

Stock's bid-ask spread

Bid-ask per $10K:

$25

Bid-ask per Share:

$0.22